000 01805 a2200505 4500
005 20250516172907.0
264 0 _c20140512
008 201405s 0 0 eng d
022 _a1744-7682
024 7 _a10.1517/14712598.2013.840285
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNakagomi, Osamu
245 0 0 _aIncorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.
_h[electronic resource]
260 _bExpert opinion on biological therapy
_cNov 2013
300 _a1613-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aBreast Feeding
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDisease Outbreaks
650 0 4 _aFeces
_xvirology
650 0 4 _aGastroenteritis
_xepidemiology
650 0 4 _aHumans
650 0 4 _aImmunity, Herd
650 0 4 _aImmunization Schedule
650 0 4 _aInfant
650 0 4 _aIntussusception
_xetiology
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRotavirus
_ximmunology
650 0 4 _aRotavirus Infections
_xepidemiology
650 0 4 _aRotavirus Vaccines
_xadministration & dosage
650 0 4 _aState Medicine
_xstandards
650 0 4 _aTwin Studies as Topic
650 0 4 _aUnited Kingdom
_xepidemiology
650 0 4 _aVaccines, Attenuated
_xadministration & dosage
700 1 _aIturriza-Gomara, Miren
700 1 _aNakagomi, Toyoko
700 1 _aCunliffe, Nigel A
773 0 _tExpert opinion on biological therapy
_gvol. 13
_gno. 11
_gp. 1613-21
856 4 0 _uhttps://doi.org/10.1517/14712598.2013.840285
_zAvailable from publisher's website
999 _c23136295
_d23136295